Maribavir for Treatment of Cytomegalovirus Infections Resistant or Refractory to Ganciclovir or Foscarnet in Hematopoietic Stem Cell Transplant or Solid Organ Transplant Recipients: A Randomized, Dose-Ranging, Double-Blind, Phase 2 Study
2017 ◽
Vol 23
(3)
◽
pp. S56-S57
◽
2017 ◽
Vol 23
(3)
◽
pp. S191-S192
◽
2018 ◽
Vol 68
(8)
◽
pp. 1255-1264
◽
2006 ◽
Vol 194
(10)
◽
pp. 1410-1421
◽
2012 ◽
Vol 14
(2)
◽
pp. 192-197
◽
2011 ◽
Vol 32
(04)
◽
pp. 471-493
◽